ICM
TISI icon

Invenomic Capital Management’s Team TISI Stock Holding History

Invenomic Capital Management’s Portfolio TISI Stock Details TISI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-7,424
Closed -$414K – 176
2020
Q2 		$414K Buy
+7,424
New +$410K 0.31% 97

Other funds holding TISI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
GI
GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return

Invenomic Capital Management's TISI Position: Q3 2020 in Review

Invenomic Capital Management sold out of Team (TISI) in Q3 2020, closing a stake of 7,424 shares — an estimated $414K sold.

Invenomic Capital Management first reported a position in TISI in Q2 2020 and held it in 1 quarter. The position peaked at $414K in Q2 2020. 114 funds tracked by Wall St. Rank hold TISI as of Q3 2020.

  • Invenomic Capital Management reported no remaining Team position as of Q3 2020 after selling out during the quarter.
  • Invenomic Capital Management sold 7,424 Team shares in Q3 2020, an estimated $414K.
  • Invenomic Capital Management first reported a position in Team in Q2 2020 and held it in 1 quarter.
  • Invenomic Capital Management's Team position peaked at $414K in Q2 2020.
  • 114 funds tracked by Wall St. Rank held Team as of Q3 2020.

Based on Invenomic Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.